User-agent: *
Disallow: /js/
Disallow: /admin/
Disallow: /App_Browser/
Disallow: /App_Code/
Disallow: /App_Data/
Disallow: /App_GlobalResources/
Disallow: /Bin/
Disallow: /Components/
Disallow: /Config/
Disallow: /controls/
Disallow: /DesktopModules/
Disallow: /Documentation/
Disallow: /flash/
Disallow: /GelMenu/
Disallow: /images/
Disallow: /Install/
Disallow: /Portals/_default/
Disallow: /Portals/0/Skins/
Disallow: /Portals/0/SiteTour/
Disallow: /Portals/0/LightBox/
Disallow: /Portals/0/MOAVideoThumbs/
Disallow: /Providers/
Disallow: /Resources/
Disallow: https://www.astrazenecaoncology.com/
Disallow: https://www.astrazenecaoncology.com/ImportantSafetyInformation.aspx
Disallow: https://www.astrazenecaoncology.com/Email-To-Friend.aspx
Disallow: https://www.astrazenecaoncology.com/privacy-statement.aspx
Disallow: https://www.astrazenecaoncology.com/legal-terms-and-conditions.aspx
Disallow: https://www.astrazenecaoncology.com/site-map.aspx
Disallow: https://www.astrazenecaoncology.com/contact-us.aspx
Disallow: https://www.astrazenecaoncology.com/clinical-trials/open-cancer-studies.aspx
Disallow: https://www.astrazenecaoncology.com/clinical-trials/cancer-study-locator.aspx
Disallow: https://www.astrazenecaoncology.com/about-us.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/pipeline-drugs.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/cancer-research-slide-decks.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/research-drug-mechanism-of-action-videos.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/anti-angiogenesis-and-proliferation.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/inhibition-vegf-signaling.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/endothelin-a-receptors.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/mek-tumor-cell-proliferation.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/src-inhibition.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/dna-repair-parp-inhibition.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/aurora-kinase-proliferation.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/DNA-Repair-Chk1.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/erbb-signaling-inhibition.aspx
Disallow: https://www.astrazenecaoncology.com/oncology-research/mammalian-target-of-rapamycin.aspx
Disallow: https://www.astrazenecaoncology.com/breast-cancer-treatment/products.aspx
Disallow: https://www.astrazenecaoncology.com/arimidex-prescribing-information.aspx
Disallow: https://www.astrazenecaoncology.com/breast-cancer-treatment/arimidex-mechanism-of-action.aspx
Disallow: https://www.astrazenecaoncology.com/faslodex-prescribing-information.aspx
Disallow: https://www.astrazenecaoncology.com/breast-cancer-treatment/faslodex-mode-of-action.aspx
Disallow: https://www.astrazenecaoncology.com/prostate-cancer-treatment/medications.aspx
Disallow: https://www.astrazenecaoncology.com/casodex-prescribing-information.aspx
Disallow: https://www.astrazenecaoncology.com/zoladex-prescribing-information.aspx
Disallow: https://www.astrazenecaoncology.com/cancer-support-network/resource.aspx
Disallow: https://www.astrazenecaoncology.com/professional-library/cancer-treatment-educational-resources.aspx
Disallow: https://www.astrazenecaoncology.com/professional-library/product-patient-education.aspx
Disallow: https://www.astrazenecaoncology.com/professional-library/cancer-medications-mechanism-of-action.aspx
Disallow: https://www.astrazenecaoncology.com/professional-library/zoladex-ordering.aspx
Disallow: https://www.astrazenecaoncology.com/professional-library/request-product-representative.aspx
Disallow: https://www.astrazenecaoncology.com/recurrent-glioblastoma-clinical-trial.pdf
Disallow: https://www.astrazenecaoncology.com/prostate-cancer-clinical-trial.pdf
Disallow: https://www.astrazenecaoncology.com/metastatic-prostate-cancer-clinical-trial.pdf
Disallow: https://www.astrazenecaoncology.com/metastatic-prostate-cancer-clinical-trial.pdf
Disallow: https://www.astrazenecaoncology.com/lung-cancer-clinical-trial.pdf
Disallow: https://www.astrazenecaoncology.com/breast-cancer-clinical-trial.pdf
Disallow: https://www.astrazenecaoncology.com/ovarian-cancer-clinical-trial.pdf
Disallow: https://www.astrazenecaoncology.com/triple-neg-breast-cancer-study.pdf
Disallow: https://www.astrazenecaoncology.com/metastatic-breast-cancer-study.pdf
Disallow: https://www.astrazenecaoncology.com/Portals/0/PPEd_SEO/advanced-breast-cancer-guide.pdf
Disallow: https://www.astrazenecaoncology.com/treatment-for-breast-cancer-relapse.pdf
Disallow: https://www.astrazenecaoncology.com/Portals/0/PPEd_SEO/faslodex-patient-guide.pdf
Disallow: https://www.astrazenecaoncology.com/Portals/0/PPEd_SEO/faslodex-treatment-calendar.pdf
Disallow: https://www.astrazenecaoncology.com/Portals/0/PPEd_SEO/understanding-breast-cancer.pdf
Disallow: https://www.astrazenecaoncology.com/Portals/0/PPEd_SEO/Understanding-Prostate-Cancer.pdf
Disallow: https://www.astrazenecaoncology.com/Portals/0/PPEd_SEO/Understanding-Prostate-Cancer-Spanish.pdf
Disallow: https://www.astrazenecaoncology.com/Portals/0/PPEd_SEO/ZOLADEX-Questions-and-Answers.pdf
Disallow: https://www.astrazenecaoncology.com/professional-library/cancer-medications-mechanism-of-action.aspx